Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Disease

Advanced Lung Neuroendocrine Tumor

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 20, 2026 · PHASE 2 TRIAL

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

ClinicalTrials.gov

This is a Phase 2 trial still recruiting with no results posted; it represents early-phase investigation of lutetium Lu 177 dotatate versus everolimus in bronchial neuroendocrine tumors.

PreliminaryFludeoxyglucose F-18 Computed Tomography National Cancer Institute (NCI)

Reported

PhasePHASE 2

Planned enrollment70

Primary outcome measureMedian progression-free survival (PFS) from…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support